GlassScriptPhysician profile
Erik L Severud
NPI 1477577674
$11,168.20
in general payments reported to CMS, 2019-2025
30 companies · $1,353 in 2025
The $1,353 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,728 · 2020: $1,220 · 2021: $219 · 2022: $1,961 · 2023: $2,761 · 2024: $1,927 · 2025: $1,353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,485 · Food and Beverage: $2,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,484.87 |
| Food and Beverage | $2,555.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $4,450.53 | 2022-2025 | Mpo Medial Pivot Knee |
| Medacta USA, INC. | $2,575.72 | 2019-2022 | |
| Titan Surgical Group, LLC | $1,679.54 | 2023-2024 | |
| Encore Medical, LP | $421.88 | 2023-2025 | Djo Surgical |
| Arthrex, INC. | $399.90 | 2024 | |
| Amgen INC. | $359.47 | 2019-2025 | Evenity, Prolia |
| Depuy Synthes Sales INC. | $274.93 | 2019-2024 | Attune, Inhance |
| Abbvie INC. | $109.32 | 2019-2021 | |
| Stryker Corporation | $97.57 | 2019-2024 | Aequalis Perform Reversed |
| Linvatec Corporation | $94.65 | 2022-2025 | Biobrace 23mm, Linvatec Arthroscopy, Hall Power |
| Smith+Nephew, INC. | $86.01 | 2021-2025 | Oasis, Grafix Pl, Stravix Pl |
| Acumed LLC | $78.09 | 2023-2024 | Inframe Implant, Innate Implant, Acumed |
| Vertex Pharmaceuticals Incorporated | $70.86 | 2025 | |
| Bioventus LLC | $66.51 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $54.07 | 2021-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $49.28 | 2022-2023 | Seglentis |
| Zyla Life Sciences, INC. | $37.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.85 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $28.39 | 2025 | Myfembree |
| Vericel Corporation | $26.11 | 2021 | |
| Next Science LLC | $23.67 | 2021 | |
| Orthalign INC | $22.96 | 2025 | Orthalign Plus |
| Heron Therapeutics, INC. | $22.74 | 2023 | Zynrelef |
| Inspire Medical Systems, INC. | $21.71 | 2025 | Inspire |
| Myovant Sciences INC. | $16.69 | 2021 | |
| Urovant Sciences INC | $15.53 | 2022 | |
| Horizon Therapeutics Plc | $13.90 | 2022 | |
| Baudax Bio INC. | $13.19 | 2021 | |
| Pacira Therapeutics, INC. | $12.82 | 2019 | |
| Therapeuticsmd, INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Severud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.